1 / 36
ENZALUTAMIDA Y SELECCIÓN DE
PACIENTES
Javier Puente, MD, PhD
Hospital Universitario Clinico San Carlos
Medical Oncology Department
Complutense University
Associate Professor of Medicine
javierpuente.hcsc@gmail.com
|
|
1 / 36
1 / 36
ENZALUTAMIDA Y SELECCIÓN DE
PACIENTES
Javier Puente, MD, PhD
Hospital Universitario Clinico San Carlos
Medical Oncology Department
Complutense University
Associate Professor of Medicine
javierpuente.hcsc@gmail.com